Compare Danaher Corporation (DHR) vs HubSpot Inc (HUBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs HubSpot Inc — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while HubSpot Inc trades at $228.3 (market cap $11.56B). The key difference: Danaher Corporation is far larger — about 13.2× HubSpot Inc's market cap, and Danaher Corporation pays a 0.74% dividend while HubSpot Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and HubSpot Inc for 78 Days on average.
| DHR | HUBS | |
|---|---|---|
Market Cap | $152.87B | $11.56B |
Volume | 5,228,698 | 1,891,287 |
Sector | Health | Technology |
52-Week High | $242.05 | $494.58 |
52-Week Low | $161.91 | $170.39 |
Typical Hold Time | 69 Days | 78 Days |
Enterprise Value | $175.08B | $10.46B |
Dividend Yield | 0.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
HubSpot (HUBS) trades at $231.84, up 5.23% today, with a bullish technical trend and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, reaching $3.13B in 2025, though profitability metrics like net margin (4.26%) remain modest. The company's AI strategy and partnership with OpenAI are key recent developments, as highlighted in September 2026 news.
The outlook is positive given earnings beats and AI initiatives, but high valuation ratios (P/E 82.51) and competitive risks warrant caution. Upside to the $243.65 consensus price target appears achievable if margin expansion continues, though volatility near resistance at $236 could test gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →
